Cargando…
Coronavirus disease 19 and risk of hyperglycemia among Iraqi patients
A cross-sectional observational study was conducted on 213 patients with COVID-19 who did not have a clinical history of diabetes at hospital admission. One week after hospitalization, they were stratified by random blood glucose levels. It was found that 25.4, 22.5 and 52.1% of COVID-19 patients we...
Autores principales: | Ad’hiah, Ali H., Al-Bayatee, Noor T., Ahmed, Aeshah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616632/ http://dx.doi.org/10.1186/s43042-021-00207-3 |
Ejemplares similares
-
HLA-G 14-bp insertion/deletion polymorphism and risk of coronavirus disease 2019 (COVID-19) among Iraqi patients
por: Ad'hiah, Ali H., et al.
Publicado: (2022) -
Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients
por: Ahmed, Aeshah A., et al.
Publicado: (2022) -
Human beta-defensins 2 and 4 are dysregulated in patients with coronavirus disease 19
por: Al-Bayatee, Noor T., et al.
Publicado: (2021) -
Soluble HLA-G is upregulated in serum of patients with severe COVID-19
por: Al-Bayatee, Noor T., et al.
Publicado: (2021) -
Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)
por: Ahmed, Aeshah A., et al.
Publicado: (2021)